Aims/Material: Hepatitis C virus (HCV) genotyping was performed in 213
anti-HCV-positive patients with chronic liver disease ranging from mi
nimal histological changes to hepatocellular carcinoma, One hundred an
d twenty-two patients had non-cirrhotic chronic active or persistent h
epatitis (including 29 who were asymptomatic with persistently normal
ALT levels) (chronic liver disease group), The other 91 had hepatocell
ular carcinoma and, in all but three cases, cirrhosis (hepatocellular
carcinoma group), Results: The overall prevalence of HCV variants was:
54.9% type 1b, 37.8% type 2, 2.5% type 1a, 2.0% type 3a, 2.0% type 4a
. The genotype distribution showed no relation to the stage (chronic l
iver disease vs, hepatocellular carcinoma) or severity (chronic active
vs, chronic persistent hepatitis) of the liver disease, or to the dur
ation of the disease (<10 years vs, >10 years), Within the hepatocellu
lar carcinoma group, the duration of type-lb disease was similar to th
at of type-2 infections, Ages at the time of infection and genotype we
re both independently associated with progression to cirrhosis and hep
atocellular carcinoma, but multivariate analysis revealed that the eff
ect of age was much stronger than that of genotype Ib. Conclusions: Th
e predominance of HCV type Ib in this study reflects the higher freque
ncy of this variant in our area, Our findings indicate that infections
caused by each HCV genotype are capable of progressing to hepatocellu
lar carcinoma.